Oklo shares are trading higher by 14.4% during Wednesday's session. The stock is gaining following a series of strategic and financial updates. Don't miss this list of 3 high-yield stocks-including one delivering over 10%-built for income in today's chaotic market.

Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial Evaluating Safety and Efficacy of ...

Acquisition of Workplace Options to Enhance TELUS Health's Global Reach and Technology Platform for Employee Assistance Programs

Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress ...

WATERTOWN, Mass., May 14, 2025 ( GLOBE NEWSWIRE ) -- Disc Medicine, Inc. ( NASDAQ:IRON ) , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it ...

- Revumenib abstracts highlight compelling results in acute leukemia across the frontline and R/R setting and multiple genetic populations, including mNPM1, KMT2Ar, and ...

Delray Beach, FL, May 14, 2025 ( GLOBE NEWSWIRE ) -- According to a research report Extended Detection and Response Market size is projected to grow from USD 1.7 billion in 2023 to USD 8.8 billion by 2028 at a Compound Annual Growth Rate ( CAGR ) of 38.4% during the forecast period, according to ...

- Revumenib abstracts highlight compelling results in acute leukemia across the frontline and R/R setting and multiple genetic populations, including mNPM1, KMT2Ar, and NUP98r - - Axatilimab abstracts highlight the robust responses observed in different organs and subgroups of patients with ...

GSK to pay $1.2 billion upfront and up to $800 million in milestones for efimosfermin, a Phase 3-ready liver disease drug. Efimosfermin showed fibrosis improvement, MASH resolution, and HbA1c reduction in 24-week Phase 2 trial.

MONTREAL, May 14, 2025 ( GLOBE NEWSWIRE ) -- Fiera Capital Corporation ( "Fiera Capital" or the "Company" ) FSZ is pleased to announce that it has entered into an agreement with Scotiabank, CIBC Capital Markets, Desjardins Capital Markets and RBC Capital Markets, as joint bookrunners, on behalf ...